Literature DB >> 9070714

Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response.

A Lass1, J Skull, E McVeigh, R Margara, R M Winston.   

Abstract

The study tests the hypothesis that small ovaries measured on transvaginal sonography (TVS) are associated with a poor response to ovulation induction by human menopausal gonadotrophin (HMG) for in-vitro fertilization (IVF). A total of 140 infertile patients with morphologically normal ovaries undergoing IVF was studied. The mean ovarian volume of each patient was measured on TVS before starting HMG. Subsequent routine IVF management was conducted without knowledge of the results of TVS. The mean ovarian volume was 6.3 cm3 (range 0.5-18.9, SD= 3.1). Patients (n = 17; group A) with small ovaries of < 3 cm3 (i.e. overall mean volume - 1 SD) were compared to patients (n = 123; group B) with ovaries > or = 3 cm3. Both groups were of similar age (mean 35.8 versus 34.4 years). Early basal FSH concentrations were increased in group A (9.5 versus 7.0 mIU/ml, P = 0.025). The cycle was abandoned before planned oocyte recovery in nine patients (52.8%) from group A and in 11 patients (8.9%) from group B because of poor response to ovulation induction (P < 0.001). Increased age and ovarian volume were associated independently with cancellation of the cycles. The remaining eight patients from group A who had oocytes retrieved required higher doses of HMG (87.5 versus 53.8 ampoules, P < 0.01), yielded fewer follicles (10.3 versus 14.5, P < 0.05) and fewer oocytes were recovered from them (6.8 versus 11.0, P < 0.05) compared with group B. There was no difference in the fertilization or pregnancy rates or the number of embryos available for transfer in either group. Our results indicate a strong association between ovarian volume and ovarian reserve. Small ovaries are associated with poor response to HMG and a very high cancellation rate during IVF. Assessment of ovarian size should be an integral part of infertility evaluation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070714     DOI: 10.1093/humrep/12.2.294

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  30 in total

1.  A prospective novel method of determining ovarian size during in vitro fertilization cycles.

Authors:  John L Frattarelli; Andrew J Levi; Bradley T Miller
Journal:  J Assist Reprod Genet       Date:  2002-01       Impact factor: 3.412

2.  Mean ovarian diameter (MOD) as a predictor of poor ovarian response.

Authors:  Iavor K Vladimirov; Desislava M Tacheva; Krassimir B Kalinov
Journal:  J Assist Reprod Genet       Date:  2004-03       Impact factor: 3.412

3.  Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH?

Authors:  R Nahum; J L Shifren; Y Chang; L Leykin; K Isaacson; T L Toth
Journal:  J Assist Reprod Genet       Date:  2001-03       Impact factor: 3.412

4.  A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment.

Authors:  Seang Lin Tan; Timothy J Child; Anthony P Cheung; Margo R Fluker; Albert Yuzpe; Robert Casper; Peter Leung; Kenneth Cadesky; Victoria J Davis
Journal:  J Assist Reprod Genet       Date:  2005-02       Impact factor: 3.412

5.  Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET?

Authors:  E al-Mizyen; L Sabatini; A M Lower; C M Wilson; T al-Shawaf; J G Grudzinskas
Journal:  J Assist Reprod Genet       Date:  2000-03       Impact factor: 3.412

6.  Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

Authors:  Cheng-Hsuan Wu; Yu-Ching Chen; Hsin-Hung Wu; Jyuer-Ger Yang; Yu-Jun Chang; Horng-Der Tsai
Journal:  J Assist Reprod Genet       Date:  2009-07       Impact factor: 3.412

7.  The significance of antral follicle size prior to stimulation in predicting ovarian response in a multiple dose GnRH antagonist protocol.

Authors:  Qiaohong Lai; Cai Chen; Zhijun Zhang; Shu Zhang; Qilin Yu; Ping Yang; Jun Hu; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

Review 8.  Different ovarian stimulation protocols for women with diminished ovarian reserve.

Authors:  D Loutradis; P Drakakis; E Vomvolaki; A Antsaklis
Journal:  J Assist Reprod Genet       Date:  2007-11-22       Impact factor: 3.412

9.  Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF.

Authors:  Mehmet Erdem; Ahmet Erdem; Rifat Gursoy; Kutay Biberoglu
Journal:  J Assist Reprod Genet       Date:  2004-02       Impact factor: 3.412

10.  Evaluation of ovarian reserve in infertile patients.

Authors:  Mehmet Fırat Mutlu; Ahmet Erdem
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.